Anebulo Pharmaceuticals Inc. (NASDAQ: ANEB)
$2.41
-0.0600 ( -2.43% ) 0.3K
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
Market Data
Open
$2.41
Previous close
$2.47
Volume
0.3K
Market cap
$62.76M
Day range
$2.34 - $2.47
52 week range
$1.62 - $4.05
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4/a | Other | 1 | Mar 08, 2024 |
4 | Insider transactions | 1 | Mar 01, 2024 |
10-q | Quarterly Reports | 49 | Feb 13, 2024 |
8-k | 8K-related | 15 | Feb 13, 2024 |
4 | Insider transactions | 1 | Dec 20, 2023 |
8-k | 8K-related | 13 | Nov 21, 2023 |
8-k | 8K-related | 14 | Nov 14, 2023 |
10-q | Quarterly Reports | 46 | Nov 14, 2023 |
def | Proxies and info statements | 3 | Oct 30, 2023 |
ars | Annual reports | 1 | Oct 30, 2023 |